FOLH1 and pancreatic neoplasm: This is in contrast to a previous study indicating PSMA as a marker of pancreatic tumor cells [19]; however, another large-scale PSMA expression analysis including a multitude of benign and malignant tissue samples and a designated focus on antibody specificity also failed to detect moderate or strong PSMA levels in PDAC [26].